4.4 Article

Establishing Serum Reference Ranges for Antihypertensive Drugs

Journal

THERAPEUTIC DRUG MONITORING
Volume 43, Issue 1, Pages 116-125

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FTD.0000000000000806

Keywords

TDM; serum drug concentration; antihypertensive drugs; adherence; personalized medicine

Funding

  1. Research Council of Norway

Ask authors/readers for more resources

This study established serum reference ranges for 24 frequently used antihypertensive drugs based on prescription data and literature review. The results suggest that combining serum drug concentration measurements, blood pressure measurements, and other clinical data may help identify nonadherent patients and tailor individualized antihypertensive treatment in line with the concept of personalized medicine.
Background: Therapeutic drug monitoring (TDM) involves the measurement of serum drug concentrations to optimize pharmacotherapy. Traditionally, blood pressure measurements alone, and not TDM, have been used to evaluate the antihypertensive drug response. However, approximately 50% of hypertensive patients treated with lifestyle changes and antihypertensive drugs fail to achieve blood pressure control. Serum drug concentration measurements could be useful to select the optimal drugs in adjusted doses and to identify nonadherence. Implementation of TDM in clinical routine for antihypertensive drugs depends on established serum reference ranges. Methods: Commonly used antihypertensive drugs were identified based on prescription data. The authors performed a review of authoritative literature on reported serum drug concentrations and calculated expected concentrations from previously reported pharmacokinetic parameters with commonly prescribed daily doses. Finally, serum drug concentrations in samples from patients undergoing antihypertensive treatment were measured. Results: Serum reference ranges for 24 frequently used antihypertensive drugs were established based on results from 3 approaches. Conclusions: Serum drug concentration measurements, interpreted in light of the established reference ranges, together with blood pressure measurements and other clinical data, may help identify nonadherent patients and tailor individual antihypertensive treatment when deviant drug responses appear in line with the concept of personalized medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available